Drug
Iodixanol clinical trials
Also written Visipaque.
- studies test it
- 12
- open now
- 0
- in phase 3
- 4
- first study started
- 2006
How studies write it
Studies that test it under each name
Name
Brand
Combined with it in one product
Studies by the year they started
12 studies that test it; most in 2006 (3)
| Year | Studies |
|---|---|
| 2006 | 3 |
| 2008 | 3 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2018 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 4
- Phase 4
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 6
GE Healthcare (5) · University of Edinburgh (1) · Enrico Ammirati (1) · Duke University (1) · Bracco Diagnostics, Inc (1) · Seoul National University Bundang Hospital (1) · Deutsches Herzzentrum Muenchen (1) · Yong Huo (1)
Often tested with
Tested in the same studies.
Iopamidol (2) · Contrast agent BR1 (1) · Iohexol (1) · Iopromide (1) · Ioversol (1)
Studies
Open first, then newest update. How each study uses iodixanol is read from its arms, and is right about nine times in ten.
Testing it · 12
- Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast MaterialCompletedPhase 4University of EdinburghNCT00558142Written as Visipaque 320
- Pediatric Risk of Hypothyroidism With Iodinated Contrast MediaWithdrawnPhase 4GE HealthcareNCT03631771Written as Iodixanol
- A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney DiseaseTerminatedPhase 4GE HealthcareNCT03119662Written as Visipaque
- Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the HeartTerminatedPhase 3GE HealthcareNCT00335335Written as iodixanol
- Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the HeartTerminatedPhase 3GE HealthcareNCT00348608Written as iodixanol
- IMaging Della PLAcca CarotideaCompletedPhase 3Enrico AmmiratiNCT03333330Written as Visipaque 320 and SonoVue
- Comparison of Isovue 370 vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)CompletedPhase 3Duke UniversityNCT02171247Written as Visipaque 320
- Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/PelvisCompletedPhase 4GE HealthcareNCT01376089Written as Iodixanol
- Renal Toxicity of Iodixanol and Iopromide in Patients With Renal DysfunctionStatus unknownPhase 4Yong HuoNCT01580046Written as iodixanol
- Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSACompletedPhase 4Bracco Diagnostics, IncNCT00740207Written as VISIPAQUE 270
- Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus IopromideCompletedPhase 4Seoul National University Bundang HospitalNCT00823628Written as contrast agent (iodixanol)
- Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)CompletedPhase 4Deutsches Herzzentrum MuenchenNCT00390585Written as Iodixanol 320
Given in every arm · 2 — iodixanol is usual care beside what is tested
- Adequate Hydration Therapy Combined With Intravenous Infusion of Isosorbide Dinitrate Prevention for CINStatus unknownNot applicableChinese PLA General HospitalNCT02718521Written as Visipaque
- Central Venous Pressure Guided Hydration Prevention for Contrast-Induced NephropathyCompletedNot applicableChinese PLA General HospitalNCT02405377Written as Visipaque
As the comparator · 1 — what is tested is compared with iodixanol
Codes
What other systems call iodixanol · ClinicalTrials.gg INT003200
- MeSH (NLM) C044834iodixanolConfirmed NLM, Wikidata
- UNII (FDA) HW8W27HTXXIODIXANOLConfirmed FDA, NLM, Wikidata
- RxNorm 27729Confirmed FDA, Wikidata
- Wikidata Q2419291iodixanolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65931IodixanolOne source FDA
- DrugBank DB01249One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C044834 | iodixanol | Confirmed NLM, Wikidata |
| UNII (FDA) | HW8W27HTXX | IODIXANOL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 27729 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2419291 | iodixanol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65931 | Iodixanol | One source FDA |
| DrugBank | DB01249 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.